EUVIMEDEUVIMED entdecken
Crossref

PP01.18: Different Lung Cancer-Associated ERBB2 Variants Exhibit Distinct Therapeutic Vulnerabilities

Paul Stockhammer, Erinda Aidoo, Keita Maemura, Lucy W. Kim, Anatoly Kiyatkin, Michael Grant, Sarah B. Goldberg, Mark A. Lemmon, Katerina Politi

Journal of Thoracic Oncology · 2026-07 · 21 (7) · 104016

DOI: 10.1016/j.jtho.2026.104016 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Thoracic Oncology, 2026-07. Verfasst von Paul Stockhammer und 8 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Stockhammer, P., Aidoo, E., Maemura, K., Kim, L. W., Kiyatkin, A., Grant, M., Goldberg, S. B., Lemmon, M. A., & Politi, K. (2026). PP01.18: Different Lung Cancer-Associated ERBB2 Variants Exhibit Distinct Therapeutic Vulnerabilities. Journal of Thoracic Oncology, 21(7), 104016. https://doi.org/10.1016/j.jtho.2026.104016

Vancouver

Stockhammer P, Aidoo E, Maemura K, Kim LW, Kiyatkin A, Grant M, et al. PP01.18: Different Lung Cancer-Associated ERBB2 Variants Exhibit Distinct Therapeutic Vulnerabilities. Journal of Thoracic Oncology. 2026;21(7):104016. doi:10.1016/j.jtho.2026.104016

BibTeX
@article{Stockhammer2026,
  author = {Stockhammer, Paul and Aidoo, Erinda and Maemura, Keita and Kim, Lucy W. and Kiyatkin, Anatoly and Grant, Michael and Goldberg, Sarah B. and Lemmon, Mark A. and Politi, Katerina},
  title = {PP01.18: Different Lung Cancer-Associated ERBB2 Variants Exhibit Distinct Therapeutic Vulnerabilities},
  journal = {Journal of Thoracic Oncology},
  year = {2026},
  volume = {21},
  number = {7},
  pages = {104016},
  doi = {10.1016/j.jtho.2026.104016}
}
Kostenlos starten →